vs
Side-by-side financial comparison of Agilent Technologies (A) and Dover Corporation (DOV). Click either name above to swap in a different company.
Dover Corporation is the larger business by last-quarter revenue ($2.1B vs $1.8B, roughly 1.2× Agilent Technologies). Agilent Technologies runs the higher net margin — 17.0% vs 13.4%, a 3.5% gap on every dollar of revenue. On growth, Dover Corporation posted the faster year-over-year revenue change (12.5% vs 7.0%). Over the past eight quarters, Agilent Technologies's revenue compounded faster (6.9% CAGR vs -1.8%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
Dover Corporation is an American conglomerate manufacturer of industrial products. The Downers Grove, Illinois-based company was founded in 1955. As of 2021, Dover's business was divided into five segments: Engineered Products, Clean Energy and Fueling, Imaging & Identification, Pumps & Process Solutions and Climate and Sustainability Technologies. Dover is a constituent of the S&P 500 index and trades on the New York Stock Exchange under the symbol DOV. Dover was ranked 448 in the 2024 Fortu...
A vs DOV — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $2.1B |
| Net Profit | $305.0M | $282.1M |
| Gross Margin | 52.6% | 39.1% |
| Operating Margin | 19.6% | 16.5% |
| Net Margin | 17.0% | 13.4% |
| Revenue YoY | 7.0% | 12.5% |
| Net Profit YoY | -4.1% | 22.2% |
| EPS (diluted) | $1.07 | $2.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | $2.1B | ||
| Q4 25 | $1.9B | $2.1B | ||
| Q3 25 | $1.7B | $2.1B | ||
| Q2 25 | $1.7B | $2.0B | ||
| Q1 25 | $1.7B | $1.9B | ||
| Q4 24 | $1.7B | $1.5B | ||
| Q3 24 | $1.6B | $2.0B | ||
| Q2 24 | $1.6B | $2.2B |
| Q1 26 | $305.0M | $282.1M | ||
| Q4 25 | $434.0M | $282.1M | ||
| Q3 25 | $336.0M | $302.0M | ||
| Q2 25 | $215.0M | $279.1M | ||
| Q1 25 | $318.0M | $230.8M | ||
| Q4 24 | $351.0M | $1.4B | ||
| Q3 24 | $282.0M | $347.1M | ||
| Q2 24 | $308.0M | $281.8M |
| Q1 26 | 52.6% | 39.1% | ||
| Q4 25 | 53.2% | 39.1% | ||
| Q3 25 | 51.1% | 40.1% | ||
| Q2 25 | 51.9% | 39.9% | ||
| Q1 25 | 53.5% | 40.0% | ||
| Q4 24 | 53.9% | 41.4% | ||
| Q3 24 | 54.2% | 38.5% | ||
| Q2 24 | 54.4% | 37.7% |
| Q1 26 | 19.6% | 16.5% | ||
| Q4 25 | 23.8% | 16.5% | ||
| Q3 25 | 20.7% | 18.2% | ||
| Q2 25 | 18.0% | 17.3% | ||
| Q1 25 | 22.4% | 15.9% | ||
| Q4 24 | 24.0% | 14.0% | ||
| Q3 24 | 21.1% | 16.8% | ||
| Q2 24 | 23.1% | 17.0% |
| Q1 26 | 17.0% | 13.4% | ||
| Q4 25 | 23.3% | 13.4% | ||
| Q3 25 | 19.3% | 14.5% | ||
| Q2 25 | 12.9% | 13.6% | ||
| Q1 25 | 18.9% | 12.4% | ||
| Q4 24 | 20.6% | 96.4% | ||
| Q3 24 | 17.9% | 17.5% | ||
| Q2 24 | 19.6% | 12.9% |
| Q1 26 | $1.07 | $2.06 | ||
| Q4 25 | $1.53 | $2.06 | ||
| Q3 25 | $1.18 | $2.19 | ||
| Q2 25 | $0.75 | $2.02 | ||
| Q1 25 | $1.11 | $1.67 | ||
| Q4 24 | $1.23 | $10.38 | ||
| Q3 24 | $0.97 | $2.51 | ||
| Q2 24 | $1.05 | $2.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | — |
| Total DebtLower is stronger | $3.0B | $3.3B |
| Stockholders' EquityBook value | $6.9B | $7.4B |
| Total Assets | $12.8B | $13.4B |
| Debt / EquityLower = less leverage | 0.44× | 0.45× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $1.7B | — |
| Q1 26 | $3.0B | $3.3B | ||
| Q4 25 | $3.0B | $3.3B | ||
| Q3 25 | $3.4B | $3.1B | ||
| Q2 25 | $3.3B | $3.1B | ||
| Q1 25 | $3.3B | $3.0B | ||
| Q4 24 | $3.3B | $2.9B | ||
| Q3 24 | $2.1B | $3.0B | ||
| Q2 24 | $2.1B | $3.0B |
| Q1 26 | $6.9B | $7.4B | ||
| Q4 25 | $6.7B | $7.4B | ||
| Q3 25 | $6.4B | $7.7B | ||
| Q2 25 | $6.1B | $7.4B | ||
| Q1 25 | $6.0B | $7.1B | ||
| Q4 24 | $5.9B | $7.0B | ||
| Q3 24 | $5.9B | $5.7B | ||
| Q2 24 | $6.2B | $5.4B |
| Q1 26 | $12.8B | $13.4B | ||
| Q4 25 | $12.7B | $13.4B | ||
| Q3 25 | $12.2B | $13.4B | ||
| Q2 25 | $12.2B | $13.2B | ||
| Q1 25 | $11.9B | $12.6B | ||
| Q4 24 | $11.8B | $12.5B | ||
| Q3 24 | $11.0B | $11.9B | ||
| Q2 24 | $10.9B | $11.3B |
| Q1 26 | 0.44× | 0.45× | ||
| Q4 25 | 0.45× | 0.45× | ||
| Q3 25 | 0.53× | 0.40× | ||
| Q2 25 | 0.55× | 0.41× | ||
| Q1 25 | 0.56× | 0.42× | ||
| Q4 24 | 0.57× | 0.42× | ||
| Q3 24 | 0.36× | 0.53× | ||
| Q2 24 | 0.34× | 0.55× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | — |
| Free Cash FlowOCF − Capex | $175.0M | — |
| FCF MarginFCF / Revenue | 9.7% | — |
| Capex IntensityCapex / Revenue | 5.2% | — |
| Cash ConversionOCF / Net Profit | 0.88× | — |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $543.9M | ||
| Q3 25 | $362.0M | $424.2M | ||
| Q2 25 | $221.0M | $212.3M | ||
| Q1 25 | $431.0M | $157.5M | ||
| Q4 24 | $481.0M | $439.0M | ||
| Q3 24 | $452.0M | $353.2M | ||
| Q2 24 | $333.0M | $203.7M |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $487.0M | ||
| Q3 25 | $259.0M | $370.1M | ||
| Q2 25 | $107.0M | $151.4M | ||
| Q1 25 | $334.0M | $109.3M | ||
| Q4 24 | $388.0M | $385.0M | ||
| Q3 24 | $360.0M | $325.0M | ||
| Q2 24 | $230.0M | $162.8M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 23.2% | ||
| Q3 25 | 14.9% | 17.8% | ||
| Q2 25 | 6.4% | 7.4% | ||
| Q1 25 | 19.9% | 5.9% | ||
| Q4 24 | 22.8% | 25.8% | ||
| Q3 24 | 22.8% | 16.4% | ||
| Q2 24 | 14.6% | 7.5% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 2.7% | ||
| Q3 25 | 5.9% | 2.6% | ||
| Q2 25 | 6.8% | 3.0% | ||
| Q1 25 | 5.8% | 2.6% | ||
| Q4 24 | 5.5% | 3.6% | ||
| Q3 24 | 5.8% | 1.4% | ||
| Q2 24 | 6.5% | 1.9% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 1.93× | ||
| Q3 25 | 1.08× | 1.40× | ||
| Q2 25 | 1.03× | 0.76× | ||
| Q1 25 | 1.36× | 0.68× | ||
| Q4 24 | 1.37× | 0.31× | ||
| Q3 24 | 1.60× | 1.02× | ||
| Q2 24 | 1.08× | 0.72× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
DOV
Segment breakdown not available.
